1.Tagrisso approved in the EU for patients with unresectable EGFR-mutated lung cancer.2.Lu S, Kato T, Dong X, Ahn MJ, Quang LV, Soparattanapaisarn N, Inoue T, Wang CL, Huang M, Yang JC, Cobo M, Özgüroğlu M, Casarini I, Khiem DV, Sriuranpong V, Cronemberger E, Takahashi T, Runglodvatana Y, Chen M, Huang X, Grainger E, Ghiorghiu D, van der Gronde T, Ramalingam SS; LAURA Trial Investigators. Osimertinib after Chemoradiotherapy in Stage IIIEGFR-Mutated NSCLC. N Engl J Med. 2024 Aug 15;391(7):585-597. doi: 10.1056/NEJMoa2402614. Epub 2024 Jun 2. PMID: 38828946.3.《中华医学会肺癌临床诊疗指南（2024版）》.4.肺癌筛查与早诊早治方案（2024年版）.(me)>我知道你在看哟↓↓
